Baccine
Baccine41About
What does Baccine do?
Baccine is a biotechnology startup focused on developing novel bacteria-based immunotherapy treatments. Their approach aims to enhance the body's anti-tumor immune response, offering potentially more effective and targeted treatment options for cancer patients.
What is Baccine's revenue?
StartupHub estimates Baccine's annual revenue at $1.5M (range $858K to $2.4M, 64% confidence), based on comparable companies in the sector.
Where is Baccine headquartered?
Baccine is headquartered in Boston, United States.
When was Baccine founded?
Baccine was founded in 2022.
What industry does Baccine operate in?
Baccine operates in Life Sciences, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Baccine have?
Baccine has approximately 9 people on record.
What is Baccine's current status?
Baccine's current operating status is: Inactive.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.